You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

repligen technical Seminar

Advances in Bioprocessing:

Industry case studies on single-use,
flexible and continuous bioprocessing

At Repligen bioprocessing seminars, thought leaders and professionals from around the world meet and review exciting new drivers of bioprocessing efficiency, learn from adopters of transformative technologies, evaluate risk landscapes and collaborate to help set the standards of modern bioproduction.

 

May 18, 2018     |     Shanghai, China

 

View Agenda

Hilton Shanghai Hongqiao

1116 Hangsong E Rd,
Minhang Qu,
Shanghai Shi, China, 201103

AGenda

Expand All

Registration will begin at 9:00 a.m. Pre-registration is required to attend.

92c3c1efb6e0b7a51e24a845542d661c_f1065.pngDr.Zhou currently is the Director of Biologics at Wuxi Apptec. He leads a team for perfusion process development of recombinant protein and mAb-based biotherapeutics, from R&D to GMP-compliant production scale, overcoming the challenge of long-term continuous perfusion culture with high cell-density, obtaining stable and good product quality.  Before joining Wuxi Apptec, Dr.Zhou worked at commercial cell culture process development department of Genzyme Corporation, and participated in perfusion cell culture process development works of a series of enzyme and mAb-based pharmaceuticals.   Dr. Zhou graduated from Chemical Engineering Department of Tsinghua University, and holds Ph.D. in chemical engineering from MIT.

Speaker Bio

31140cde470a6e2b975d20f86a0b3225_f1067.jpgDr. Lin is currently the Director of Downstream Process Developing at CGB/ChemPartner. He brings 10 years’ experience of in biologics development and manufacturing with Assay development, fermentation, purification and formulation. Dr. Lin has set up PD/AD/QC labs and pilot/commercial single-use systems from 50L up to 2K. He previously held roles at JHL Biotech, PharmaEssentia, Purzer Pharmaceuticals and YungShin Pharma. Dr. Lin holds a Bachelor’s of Science degree from National Chung Hsing University, a Master’s in Chemical Engineering from Chung Yuan Christian University and a Ph.D. in Chemical Engineering from National Taiwan University.

Speaker Bio

eb52de333cf7223d554f4bd8960dfd94_f1064.jpgMr. Audouy is currently Asia Sales Director for Repligen. Based out of Singapore, he supports the rapidly expanding Asian market as the Repligen leading product portfolio continues to expand. Mr. Audouy began working in the bioprocess industry in 2002 and has worked with various technologies and has previously held roles at Constant Systems Ltd and Refine Technology.  Mr. Audouy graduated from the Daventry Campus of Northampton College, Northants, UK with A-Levels in Physics, Electronics, French and English Literature.

Speaker Bio

d775ae7db04b92da07b13356ca66f3eb_f1068.jpgMr. Gao is currently the Process Manager for GMP production process development and pilot production of plasmid, lentivirus and CAR-T cells at the Suzhou Ctigen Medical Technology Co., Ltd.  He brings 13 years’ experience of downstream biotherapeutic process development, pilot scale-up, technology transfer and CMO production (especially in CAR-T, monoclonal antibody, cell factors), participated in production technology transfer for Australia, India and England clinical trial applications, and has spent several years in team management. Mr.Gao previously held roles at JW Biotechnology, BioMabs and Jintao Biotechnology of Northern China Pharmaceutical group. Mr. Gao holds MSc in biochemical engineering from East China University of Science and Technology.

Speaker Bio

b12fca5cc223bb015b5e5c95f4cdaf48_f1077.jpgMr. Guodong Chang is currently the Vice Director of National Engineering Laboratory of Anti-cancer protein drugs and also the CEO of Beijing Protgen Bioscience development Co.,Ltd., and it’s related companies. Mr. Chang has 20 years experiences of biotechnology and biopharmaceutical development, especially in recombinant protein therapeutics research and production application development. As leading scientist, developed several new drugs, which are successfully approved by China and/or EU market.

Abstract

Implementation of single-use alternatives in tangential flow filtration (TFF), a critical step in concentration and diafiltration (buffer exchange), is becoming platform in downstream bioprocessing. Repligen TangenX™ SIUS™ Single-use Cassettes are the first purpose-built cassettes designed for tangential flow filtration. This presentation will demonstrate how deploying these innovative cassettes can help reduce filter cost by 80%, reduce labor costs by 50%, and reduce buffer and water usage by 75% when compared to traditional reusable cassettes.

Speaker Bio

bianchi.jpgMr. Bianchi is currently the Field Applications Specialist for Repligen downstream TFF products. He brings over 20 years of experience in process filtration and separation with a significant portion of that time focused on Tangential Flow Filtration applications utilizing flat sheet cassettes and hollow fiber modules. Mr. Bianchi has held various technical positions supporting Pall Corporation, Spectrum Laboratories, FloDesign Sonics and TangenX™. He holds a Bachelor of Science degree in Chemistry from Worcester Polytechnic Institute.

There is no charge for attendance but registration is required. Seats are limited to end-users of bioprocessing tools and technologies. Travel, accomodations, and incidental expenses are the responsibility of attendees. Lunch will be served.

Questions? Email EVENTS@REPLIGEN.COM